Vasomotor Symptoms

Vasomotor Symptoms Market Outlook

The global vasomotor symptoms market is projected to reach USD 15.5 billion by 2035, growing at a CAGR of 7.2% from 2025 to 2035. This robust growth can be attributed to the increasing prevalence of hormonal imbalances, particularly among aging populations, as well as the growing awareness and acceptance of various treatment options. The rise in the number of women experiencing menopause and the corresponding vasomotor symptoms, such as hot flashes and night sweats, is driving demand for effective therapies. Additionally, advancements in pharmaceutical research are leading to the development of innovative products aimed at alleviating these symptoms, which further contributes to market growth. Growing consumer interest in natural and holistic remedies is shaping the therapeutic landscape, encouraging companies to diversify their product offerings and cater to a broader audience.

Growth Factor of the Market

Several factors are propelling the growth of the vasomotor symptoms market. First, the aging population is a significant driver, as an increase in life expectancy leads to a higher incidence of menopausal and andropausal symptoms. This demographic shift places a greater demand on healthcare providers for effective management and treatment options. Second, the rise in awareness and education surrounding hormone therapy and non-hormonal alternatives is empowering patients to seek appropriate care. Additionally, the expansion of online retail channels and the accessibility of healthcare services have enhanced patient access to treatment options. The growing trend of integrative health approaches, emphasizing lifestyle changes and natural remedies, is also influencing consumer preferences. Lastly, ongoing research and development efforts to create novel therapies are expected to introduce more effective and safer options into the market.

Key Highlights of the Market

• The global vasomotor symptoms market is expected to grow at a CAGR of 7.2% from 2025 to 2035.
• Hormone therapy remains the dominant product type, attributed to its widespread use and effectiveness.
• There is an increasing trend towards non-hormonal therapies and herbal remedies, reflecting a shift in consumer preferences.
• North America holds the largest market share, driven by a higher awareness of treatment options and robust healthcare infrastructure.
• Online retail channels are becoming increasingly popular, providing greater access to a variety of treatment options for consumers.

By Product Type

Hormone Therapy:

Hormone therapy remains the most commonly prescribed treatment for vasomotor symptoms, particularly for women experiencing menopause. This type of therapy involves the administration of estrogen, progesterone, or a combination of both, and is effective in alleviating symptoms such as hot flashes, night sweats, and mood swings. Despite its efficacy, hormone therapy is often associated with potential risks, including cardiovascular complications and certain cancers. Consequently, healthcare providers must carefully evaluate the benefits and risks for each patient, tailoring treatment plans accordingly. Recent advancements in hormone delivery systems, such as transdermal patches and gels, are enhancing patient compliance and reducing side effects, further driving the acceptance of hormone therapy as a viable treatment option.

Non-Hormonal Therapy:

Non-hormonal therapies have gained popularity as an alternative for patients who prefer to avoid hormone treatments due to health concerns or personal preferences. These therapies include medications such as selective serotonin reuptake inhibitors (SSRIs), gabapentin, and clonidine, which help alleviate vasomotor symptoms without the use of hormones. Non-hormonal treatments are particularly appealing for individuals with contraindications to hormone therapy or those who have experienced side effects. The effectiveness of these treatments can vary among patients, leading to a personalized approach that may require trial and error. However, the increasing acceptance of non-hormonal options is contributing to the overall growth of the vasomotor symptoms market.

Herbal Remedies:

Herbal remedies are increasingly sought after as natural alternatives for managing vasomotor symptoms. Ingredients such as black cohosh, red clover, and dong quai have been traditionally used to alleviate symptoms associated with menopause and hormonal imbalances. These remedies are often perceived as safer and less invasive options compared to pharmaceutical therapies. Clinical studies have shown mixed results regarding the efficacy of herbal remedies; however, their popularity continues to rise due to a growing preference for holistic health approaches. Manufacturers are responding to this demand by developing herbal supplements and products specifically formulated to target vasomotor symptoms, thereby expanding the market presence of herbal options.

Lifestyle Changes:

Lifestyle changes play a crucial role in managing vasomotor symptoms and are often recommended alongside other treatment modalities. Simple adjustments, such as incorporating regular exercise, maintaining a balanced diet, practicing stress management techniques, and avoiding triggers like caffeine and alcohol, can significantly improve symptom management. Healthcare providers increasingly emphasize the importance of lifestyle modifications as an integral part of treatment plans, encouraging patients to take an active role in their health. This holistic approach not only enhances overall well-being but also empowers patients by providing them with effective self-management strategies that complement pharmacological interventions.

Prescription Medications:

Prescription medications encompass a range of pharmaceuticals specifically aimed at alleviating vasomotor symptoms. These include both hormone-based and non-hormonal options, as well as off-label uses of existing medications. The introduction of new prescription drugs, which target vasomotor symptoms with improved efficacy and reduced side effects, is expected to bolster market growth. The availability of these medications through healthcare providers and pharmacies ensures that patients have access to tailored treatments. However, the potential for side effects and the requirement for medical supervision underscore the importance of consultations with healthcare professionals to determine the most appropriate treatment course for each individual.

By Application

Menopause:

Menopause is the primary application driving the vasomotor symptoms market, as it is strongly associated with the onset of symptoms such as hot flashes and night sweats. As women enter this phase of life, their bodies experience significant hormonal fluctuations that can lead to uncomfortable and disruptive symptoms. The increase in the aging female population globally presents a growing market for products aimed at alleviating menopause-related symptoms. Healthcare providers play a key role in educating women about available treatment options, helping them navigate the various therapies and lifestyle modifications that can effectively manage their symptoms. The focus on menopause in both clinical practice and product development is a key factor in the sustained demand for vasomotor symptom treatments.

Andropause:

Andropause, often referred to as male menopause, is another important application in the vasomotor symptoms market. While not as widely recognized as menopause, andropause involves hormonal changes that can lead to symptoms such as reduced libido, fatigue, and mood disturbances in aging men. As awareness of andropause increases, there is a growing demand for effective treatment solutions to manage these symptoms. Healthcare providers are beginning to acknowledge and address andropause in clinical settings, leading to the development of targeted therapies and lifestyle recommendations. This evolving understanding of male hormonal changes and their impact on quality of life is expected to drive growth in the vasomotor symptoms market.

Other Hormonal Imbalances:

Other hormonal imbalances, including those caused by conditions such as polycystic ovary syndrome (PCOS) and thyroid disorders, represent an additional application area within the vasomotor symptoms market. These conditions can lead to a variety of symptoms, including irregular menstrual cycles, weight gain, and mood fluctuations. Treatments targeting these hormonal imbalances often overlap with vasomotor symptom management, as patients may experience a range of interconnected symptoms. The increasing recognition of the impact of hormonal health on overall well-being is prompting healthcare professionals to adopt a more integrative approach, encompassing both hormonal and non-hormonal treatments. As a result, the market for managing symptoms associated with hormonal imbalances is expected to expand as awareness and education continue to grow.

By Distribution Channel

Pharmacies:

Pharmacies remain one of the most significant distribution channels for vasomotor symptom treatments. They offer a convenient location for patients to access both prescription and over-the-counter medications, ensuring that individuals have easy access to necessary treatments. Community pharmacies are often staffed with knowledgeable pharmacists who can provide guidance on medication choices and potential side effects. The presence of established pharmacy chains, as well as independent pharmacies, ensures a wide distribution network that caters to varying patient needs. In addition to traditional brick-and-mortar pharmacies, many are expanding their services to include online ordering options, further enhancing accessibility for patients seeking relief from vasomotor symptoms.

Online Retailers:

Online retailers are quickly becoming a vital distribution channel for the vasomotor symptoms market. The convenience of purchasing medications and supplements online appeals to a growing number of consumers who prefer to shop from the comfort of their homes. This trend has been accelerated by the COVID-19 pandemic, which prompted many to explore online healthcare options. E-commerce platforms provide a vast array of products, including hormone therapies, herbal remedies, and lifestyle supplements, allowing patients to compare options and select the most suitable treatments. The ease of access to information and customer reviews further fosters informed decision-making, making online retail an increasingly popular choice for managing vasomotor symptoms.

Hospitals & Clinics:

Hospitals and clinics are essential distribution channels for vasomotor symptom treatments, particularly for patients requiring immediate medical attention or specialized care. Healthcare providers in these settings are equipped to diagnose hormonal imbalances and recommend appropriate therapies tailored to individual needs. Patients often receive comprehensive treatment plans that may include medication prescriptions, lifestyle modifications, and follow-up care. In addition to offering pharmaceutical options, hospitals and clinics provide valuable educational resources to empower patients in managing their symptoms effectively. The collaborative approach involving healthcare professionals ensures that patients receive holistic care, which is likely to sustain the demand for treatments through these channels.

Supermarkets/Hypermarkets:

Supermarkets and hypermarkets are emerging as alternative distribution channels for over-the-counter treatments and herbal remedies targeting vasomotor symptoms. These retail locations often feature dedicated health and wellness sections where consumers can find various products aimed at alleviating symptoms. The visibility of these products in high-traffic retail environments increases awareness and accessibility for consumers who may not seek treatment through traditional healthcare avenues. By offering a range of options, including herbal supplements and dietary changes, supermarkets/hypermarkets contribute to the diversified supply chain for managing vasomotor symptoms. The combination of convenience and accessibility enhances the overall market presence for these treatment options.

By Ingredient Type

Phytoestrogens:

Phytoestrogens, plant-derived compounds that mimic estrogen in the body, are increasingly utilized in products targeting vasomotor symptoms. These natural ingredients have gained popularity due to their potential to alleviate symptoms such as hot flashes and mood swings without the associated risks of hormone therapy. Phytoestrogens can be found in various food sources, including soy products, flaxseeds, and whole grains, as well as in dietary supplements. Research suggests that phytoestrogens can effectively modulate hormonal activity, providing a gentler alternative for individuals seeking relief from menopausal symptoms. The rising consumer interest in natural therapies is driving the demand for products containing phytoestrogens, contributing to their significant role in the vasomotor symptoms market.

Black Cohosh:

Black cohosh is a widely recognized herbal remedy that has been traditionally used to treat menopausal symptoms, particularly vasomotor symptoms like hot flashes and night sweats. The active compounds in black cohosh are believed to exert estrogen-like effects, offering relief to women experiencing discomfort during menopause. Numerous studies have highlighted its efficacy in reducing the frequency and intensity of hot flashes, contributing to its popularity among natural treatment options. As consumers increasingly seek alternative solutions for hormonal imbalances, the demand for black cohosh supplements is expected to grow. Manufacturers are capitalizing on this trend by formulating products that incorporate black cohosh alongside other beneficial ingredients, thereby enhancing their market appeal.

Soy:

Soy is another ingredient that has garnered attention for its potential benefits in managing vasomotor symptoms. Rich in isoflavones, a type of phytoestrogen, soy is believed to help regulate hormonal fluctuations experienced during menopause. Research suggests that consuming soy products can lead to a significant reduction in the frequency of hot flashes and associated discomfort. The versatility of soy makes it an attractive ingredient, as it can be incorporated into various forms such as supplements, beverages, and food products. As dietary patterns shift towards plant-based and health-conscious choices, the incorporation of soy into wellness products is likely to gain momentum, positioning it as a vital ingredient in the vasomotor symptoms market.

Red Clover:

Red clover is a flowering plant known for its high content of isoflavones, which are similar in structure to estrogen. This characteristic has led to its popularity as a natural remedy for managing vasomotor symptoms associated with menopause. Numerous studies have investigated the effectiveness of red clover in alleviating hot flashes and improving overall hormonal balance. Its appeal lies in its natural origin and generally favorable safety profile, making it an attractive option for consumers seeking alternative therapies. As the trend towards holistic and natural health solutions continues to grow, red clover is likely to gain traction in the vasomotor symptoms market, particularly within herbal supplement formulations.

Dong Quai:

Dong quai, also known as "female ginseng," is a traditional Chinese herb that has been used for centuries to address women's health issues, including hormonal imbalances and vasomotor symptoms. It is often employed as a remedy for menstrual irregularities and menopausal discomfort. Dong quai is believed to possess adaptogenic properties, helping the body cope with hormonal fluctuations and alleviate symptoms such as hot flashes and mood swings. Despite its historical use, research on dong quai's effectiveness is still ongoing, and results are mixed. Nevertheless, its longstanding reputation in herbal medicine contributes to its presence in the vasomotor symptoms market, appealing to consumers looking for natural and time-tested remedies.

By Region

North America dominates the vasomotor symptoms market, accounting for approximately 40% of the global share. The region's strong healthcare infrastructure, coupled with a high level of awareness regarding treatment options, contributes to this significant market presence. The aging population in the United States and Canada is particularly susceptible to hormonal imbalances, resulting in increased demand for effective therapies. Furthermore, the growing acceptance of both hormonal and non-hormonal treatment options enhances the market's growth potential. The projected CAGR for North America during the forecast period is estimated to be around 7.5%, indicating a continuous upward trajectory for the region.

Europe holds the second-largest market share, representing around 30% of the global vasomotor symptoms market. The growing aging population and increasing awareness of menopause and andropause symptoms are driving demand for effective management solutions. European countries are witnessing a shift toward natural and holistic treatments, leading to increased interest in herbal remedies and non-hormonal therapies. The projected CAGR for Europe is estimated to be 6.8%, as healthcare systems increasingly focus on providing comprehensive treatment options that address the needs of patients experiencing vasomotor symptoms. As awareness continues to rise, the European market is expected to expand significantly during the forecast period.

Opportunities

The vasomotor symptoms market presents numerous opportunities for growth, primarily driven by advancements in research and product development. As scientific understanding of hormonal balance and its impact on overall health continues to evolve, there is an increasing demand for innovative therapies that address the diverse needs of patients. Companies that invest in research and development to create novel treatment options, including combination therapies and personalized medicine approaches, are likely to gain a competitive edge. Furthermore, the integration of technology in healthcare, such as telehealth consultations and mobile health applications, creates opportunities for reaching a broader audience and improving patient access to care. By capitalizing on these trends, market players can position themselves for success in an evolving landscape.

Another significant opportunity lies in the growing interest in natural and organic products. Consumers are increasingly seeking alternatives to traditional pharmaceuticals, leading to a surge in demand for herbal remedies and dietary supplements. Companies that focus on developing high-quality, clinically backed natural products can tap into this growing segment of health-conscious consumers. Additionally, partnerships with healthcare providers and wellness influencers can enhance product visibility and credibility. As the market for natural treatments expands, companies that prioritize sustainability and transparency in their sourcing and manufacturing processes will likely resonate with consumers, further driving their success in the vasomotor symptoms market.

Threats

Despite the numerous opportunities in the vasomotor symptoms market, there are potential threats that may impact growth. One significant concern is the increasing regulatory scrutiny surrounding the development and marketing of healthcare products. As governments and regulatory bodies implement stricter guidelines to ensure the safety and efficacy of treatments, companies may face challenges in bringing new products to market. Compliance with these regulations can result in increased costs and longer timelines for development, which may hinder innovation and slow the introduction of novel therapies. Additionally, the competitive landscape is becoming increasingly crowded, with numerous players vying for market share. This intensifying competition could lead to pricing pressures and reduced profit margins for manufacturers.

Another potential threat to the vasomotor symptoms market is the availability of counterfeit products, particularly in the online retail space. As the demand for treatments increases, so does the risk of counterfeit and substandard products entering the market, posing safety concerns for consumers. This trend underscores the importance of consumer education regarding the sourcing and purchasing of treatments. Companies must prioritize quality assurance and establish robust supply chain management practices to combat these threats effectively. By maintaining high standards and transparent practices, businesses can build consumer trust and mitigate the risks associated with counterfeit products.

Competitor Outlook

• SABINSA Corporation
• P&G (Procter & Gamble)
• Pfizer Inc.
• Amgen Inc.
• Teva Pharmaceuticals
• Hyaluronic Acid Corporation
• Novartis AG
• GSK (GlaxoSmithKline)
• AbbVie Inc.
• Merck & Co., Inc.
• Rugby Laboratories
• Solvay S.A.
• BioCare Copenhagen A/S
• HRA Pharma
• Herbalife International, Inc.

The competitive landscape of the vasomotor symptoms market is characterized by a mix of established pharmaceutical companies and emerging players specializing in natural remedies and dietary supplements. Major pharmaceutical companies, such as Pfizer, AbbVie, and Merck, dominate the market due to their extensive research and development capabilities, robust distribution networks, and established brand presence. These companies focus on developing innovative treatments that cater to the needs of patients experiencing vasomotor symptoms. In addition, they invest heavily in marketing and educational initiatives to raise awareness about the available treatment options, thus enhancing their competitive position in the market.

Emerging players in the market are increasingly focusing on herbal remedies and non-hormonal therapies, catering to the growing consumer preference for natural alternatives to traditional treatments. Companies like Herbalife and BioCare Copenhagen are capitalizing on this trend by offering high-quality, clinically backed supplements designed specifically for managing vasomotor symptoms. These emerging players often emphasize sustainability and transparency in their sourcing and manufacturing processes, which resonates with consumers seeking trustworthy and effective products. As the market evolves, collaboration between traditional pharmaceutical companies and emerging natural remedy brands may lead to innovative product offerings that appeal to a broader audience.

The market's competitive dynamics are also influenced by ongoing research and development efforts, with companies striving to stay ahead of the curve by introducing new formulations and delivery methods. The collaboration between academia and industry is fostering innovation, leading to the discovery of novel compounds and treatment modalities. Additionally, strategic partnerships and mergers are becoming increasingly common, allowing companies to expand their product portfolios and enhance their market presence. As the vasomotor symptoms market continues to grow, the competitive landscape will remain dynamic, with both established and emerging players vying for market share and customer loyalty.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Amgen Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 HRA Pharma
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 AbbVie Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Novartis AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Pfizer Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Solvay S.A.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Merck & Co., Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Rugby Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 SABINSA Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Teva Pharmaceuticals
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 GSK (GlaxoSmithKline)
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 BioCare Copenhagen A/S
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 P&G (Procter & Gamble)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Hyaluronic Acid Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Herbalife International, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Vasomotor Symptoms Market, By Application
    • 6.1.1 Menopause
    • 6.1.2 ropause
    • 6.1.3 Other Hormonal Imbalances
  • 6.2 Vasomotor Symptoms Market, By Product Type
    • 6.2.1 Hormone Therapy
    • 6.2.2 Non-Hormonal Therapy
    • 6.2.3 Herbal Remedies
    • 6.2.4 Lifestyle Changes
    • 6.2.5 Prescription Medications
  • 6.3 Vasomotor Symptoms Market, By Ingredient Type
    • 6.3.1 Phytoestrogens
    • 6.3.2 Black Cohosh
    • 6.3.3 Soy
    • 6.3.4 Red Clover
    • 6.3.5 Dong Quai
  • 6.4 Vasomotor Symptoms Market, By Distribution Channel
    • 6.4.1 Pharmacies
    • 6.4.2 Online Retailers
    • 6.4.3 Hospitals & Clinics
    • 6.4.4 Supermarkets/ Hypermarkets
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Vasomotor Symptoms Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Vasomotor Symptoms market is categorized based on

By Product Type

• Hormone Therapy
• Non-Hormonal Therapy
• Herbal Remedies
• Lifestyle Changes
• Prescription Medications

By Application

• Menopause
• ropause
• Other Hormonal Imbalances

By Distribution Channel

• Pharmacies
• Online Retailers
• Hospitals & Clinics
• Supermarkets/ Hypermarkets
• Others

By Ingredient Type

• Phytoestrogens
• Black Cohosh
• Soy
• Red Clover
• Dong Quai

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• SABINSA Corporation
• P&G (Procter & Gamble)
• Pfizer Inc.
• Amgen Inc.
• Teva Pharmaceuticals
• Hyaluronic Acid Corporation
• Novartis AG
• GSK (GlaxoSmithKline)
• AbbVie Inc.
• Merck & Co., Inc.
• Rugby Laboratories
• Solvay S.A.
• BioCare Copenhagen A/S
• HRA Pharma
• Herbalife International, Inc.